Xintela AB (publ)

Xintela AB (publ)verified

XINT.ST

Price:

$0.254

Market Cap:

$178.65M

Xintela AB (publ), a biomedical company, operates in the fields of regenerative medicine and cancer, focusing on cartilage damage and brain tumors. The company develops products based on XINMARK, a patented marker technology that identifies and selects a range of stem cells, which can develop cartilage cells. It is also developing XSTEM a stem cell product that is in clinical development phase for the treatment of knee osteoarthritis and difficult-to-heal leg ulcers; and EQSTEM, a stem cell product for the treatment of joint diseases in horses, as well as focuses on the preclinical development of therapeutic antibodies for aggressive cancers, including brain tumor glioblastoma and triple neg...[Read more]

Industry

Biotechnology

IPO Date

2016-03-22

Stock Exchange

STO

Ticker

XINT.ST

The Enterprise Value as of December 2025 (TTM) for Xintela AB (publ) (XINT.ST) is 175.27M

According to Xintela AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 175.27M. This represents a change of -26.63% compared to the average of 238.89M of the last 4 quarters.

Xintela AB (publ) (XINT.ST) Historical Enterprise Value (quarterly & annually)

How has XINT.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Xintela AB (publ) over the last ten years is 193.34M. The current 175.27M Enterprise Value has changed 8.97% with respect to the historical average. Over the past ten years (40 quarters), XINT.ST's Enterprise Value was at its highest in in the March 2019 quarter at 412.12M. The Enterprise Value was at its lowest in in the June 2022 quarter at 41.75M.

Quarterly (TTM)
Annual

Average

193.34M

Median

158.38M

Minimum

79.61M

Maximum

312.05M

Xintela AB (publ) (XINT.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Xintela AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 131.93%

Maximum Annual Enterprise Value = 312.05M

Minimum Annual Increase = -74.49%

Minimum Annual Enterprise Value = 79.61M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024172.51M62.78%
2023105.98M33.13%
202279.61M-74.49%
2021312.05M18.60%
2020263.11M-11.38%
2019296.91M-3.77%
2018308.55M131.93%
2017133.04M-7.77%
2016144.25M22.86%
2015117.41M-12.42%

Xintela AB (publ) (XINT.ST) Average Enterprise Value

How has XINT.ST Enterprise Value performed in the past?

The current Enterprise Value of Xintela AB (publ) (XINT.ST) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

119.36M

5-year avg

186.65M

10-year avg

193.34M

Xintela AB (publ) (XINT.ST) Enterprise Value vs. Peers

How is XINT.ST’s Enterprise Value compared to its peers?

Xintela AB (publ)’s Enterprise Value is less than Elicera Therapeutics AB (publ) (250.47M), greater than Intervacc AB (publ) (133.77M), less than Acarix AB (publ) (323.95M), less than Ascelia Pharma AB (publ) (278.52M), less than Mendus AB (publ) (215.77M), greater than Karolinska Development AB (publ) (57.49M), less than Nanexa AB (publ) (496.35M), less than Lipum AB (publ) (341.46M), greater than Bio-Works Technologies AB (publ) (157.10M), greater than IRLAB Therapeutics AB (publ) (84.30M),

Build a custom stock screener for Xintela AB (publ) (XINT.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Xintela AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Xintela AB (publ) (XINT.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Xintela AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Xintela AB (publ)'s Enterprise Value?

What is the highest Enterprise Value for Xintela AB (publ) (XINT.ST)?

What is the 3-year average Enterprise Value for Xintela AB (publ) (XINT.ST)?

What is the 5-year average Enterprise Value for Xintela AB (publ) (XINT.ST)?

How does the current Enterprise Value for Xintela AB (publ) (XINT.ST) compare to its historical average?